Western blot analysis indicated that the balance in Bcl-2 family proteins was perturbed in NSCLC cells treated with ARu-B, as well as the decrease in the level of full-length caspase 3 and PARP (Fig 8C). Here, BCL2 is linked to non-small cell lung carcinoma.